Filter
529
Filtered Results: 529
Text search:
molecular
markers
Featured
Recommendations
68
New Publications
104
Language
Document type
No document type
242
Guidelines
112
Studies & Reports
98
Manuals
36
Strategic & Response Plan
18
Fact sheets
10
Training Material
7
Situation Updates
5
Resource Platforms
1
Countries / Regions
India
43
Global
23
Africa
14
Latin America and the Carribbean
13
Kenya
12
Tanzania
12
Western and Central Europe
12
Ethiopia
8
Eastern Europe
8
South Africa
7
South–East Asia Region
6
Philippines
5
East and Southern Africa
5
West and Central Africa
5
Sierra Leone
4
Nigeria
4
Uganda
4
Zimbabwe
4
Indonesia
4
Western Pacific Region
4
Asia
4
Cameroon
3
Nepal
3
Pakistan
3
Malawi
3
Brazil
3
Myanmar / Burma
3
Guinea
2
Liberia
2
Congo, Democratic Republic of
2
USA
2
Zambia
2
Syria
2
Benin
2
Ukraine
2
Middle East and North Africa
2
Venezuela
2
North America
2
Burkina Faso
1
Senegal
1
Côte d’Ivoire / Ivory Coast
1
Ghana
1
Somalia
1
Jordan
1
Afghanistan
1
Germany
1
Lebanon
1
Chad
1
Cambodia
1
Thailand
1
China
1
Rwanda
1
Malaysia
1
Bangladesh
1
Namibia
1
Peru
1
Eswatini/ Swaziland
1
North Macedonia
1
Angola
1
Lesotho
1
Eastern Europe and Central Asia
1
Timor Leste/ East Timor
1
Georgia
1
Vietnam
1
Japan
1
United Kingdom
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
136
Clinical Guidelines
97
Public Health
38
Pharmacy & Technologies
24
Key Resources
14
Women & Child Health
12
Capacity Building
4
Toolboxes
TB
75
COVID-19
56
AMR
48
HIV
36
NTDs
31
Rapid Response
29
Mental Health
28
Planetary Health
17
NCDs
14
Ebola
10
Refugee
8
Pharmacy
8
Polio
5
Zika
5
Specific Hazards
4
Cholera
3
Conflict
3
Global Health Education
3
Caregiver
3
Disability
2
Natural Hazards
2
Health Financing Toolbox
1
Intensive Care Med (2009) 35:9–29DOI 10.1007/s00134-008-1336-9
Although thousands of papers have been devoted tohospital-acquired pneumonia (HAP), many controversiesremain, and management of HAP is probably often sub-optimal. Several reviews or guidelines have been pub-lished rec...
This policy brief has been developed in response to the contemporary challenge of antibiotic resistance (ABR). ABR poses a formidable threat to global health and sustainable development. It is now increasingly recognized that the systematic neglect of cultural factors is one of the biggest obs...
The WHO COVID-19 Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is ...
Updated July 3, 2020
This module is part of the WHO series The Immunological Basis for Immunization, which was initially developed in 1993 as a set of eight modules, comprising one module on general immunology and seven modules each devoted to one of the vaccines recommended for the Expanded Programme on Immunization, i...
The Global Strategy for Tuberculosis Research and Innovation will support the efforts of governments and other stakeholders to accelerate TB research and innovation, and improve equitable access to the benefits of research.
Availabl in Arabic, Chinese, English, French, Spanish and Russian
A Global Analysis of Antimicrobial Resistance and Its Drivers.
Since the first State of the World’s Antibiotics report in 2015, antimicrobial resistance has leveled off in some high-income countries but continues to rise in many low- and middle-income countries (LMICs), where access to antibiotic...
The key areas covered are diagnosis, imaging, pathology, surgery, rehabilitation, palliative care and survivorship. It emphasizes a multi-disciplinary team approach which is paramount for quality cancer care. The specific cancers covered are breast, central nervous system, gastroint...
Interim Guidance October 2022. This addendum addresses some of the methodological aspects of VE evaluations that have been learned during the past year, as well as those that have become relevant in the current epidemiological setting of the COVID-19 pandemic. For some of the COVID-19 vaccine method...
COVID-19 Vaccines: 1 Safety Surveillance 2 Manual
While there is no indication that pregnant women have an increased susceptibility to infection with SARS-CoV-2, there is evidence that pregnancy may increase the risk of severe illness and mortality from COVID-19 disease in comparison with non-pregn...
On 9 February 2021, a first webinar entitled “Expanding our understanding of Post COVID-19 condition” was held under the auspices of WHO and in consultation with the International Severe Acute Respiratory and Emerging Infection Consortium(ISARIC), Global Research Collaboration for Infectious Dis...
Interim guidanceAnnex to: Policy considerations for implementing a risk-based approach to international travel in the context of COVID-19, 2 July 2021
13 July 2021
The module provides an overview of factors to consider when monitoring the safety of COVID-19 vaccines administered to pregnant and breastfeeding women. It describes how national routine AEFI surveillance should be adapted to cater for this specific group of population using both pass...
